Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Saslow, C. Boetes, W. Burke, S. Harms, M. Leach, C. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, Robert Smith, E. Warner, M. Yaffe, Kimberly Andrews, C. Russell (2007)
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to MammographyCA: A Cancer Journal for Clinicians, 57
R. Henry-Tillman, S. Harms, K. Westbrook, S. Korourian, V. Klimberg (1999)
Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy.American journal of surgery, 178 6
(2006)
di - agnostics and therapeutics
A. Murray, R. Staff, T. Redpath, F. Gilbert, A. Ah-See, J. Brookes, I. Miller, S. Payne (2002)
Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes.The British journal of radiology, 75 891
Giuliano (1994)
Lymphatic mapping and sentinel lymphadenectomy for breast cancerAnn Surg, 220
B. Szabó, P. Aspelin, M. Wiberg, T. Tot, B. Bóné (2003)
Invasive breast cancer: correlation of dynamic MR features with prognostic factorsEuropean Radiology, 13
D. Hsiang, Maki Yamamoto, R. Mehta, M. Su, Choong Baick, K. Lane, J. Butler (2007)
Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.Archives of surgery, 142 9
D. Fuster, J. Duch, P. Paredes, M. Velasco, M. Muñoz, G. Santamaría, M. Fontanillas, F. Pons (2008)
Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 29
A. Cuenca, Huabei Jiang, S. Hochwald, M. Delano, W. Cance, S. Grobmyer (2006)
Emerging implications of nanotechnology on cancer diagnostics and therapeuticsCancer, 107
L. Liberman, G. Mason, Elizabeth Morris, D. Dershaw (2006)
Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size.AJR. American journal of roentgenology, 186 2
S. Masood (2005)
Prognostic/predictive factors in breast cancer.Clinics in laboratory medicine, 25 4
F. Clayton, Charlotte Hopkins (1993)
Pathologic correlates of prognosis in lymph node‐positive breast carcinomasCancer, 71
M. Kelley, N. Hansen, K. McMasters (2004)
Lymphatic mapping and sentinel lymphadenectomy for breast cancer.American journal of surgery, 188 1
K. Kvistad, J. Rydland, H. Smethurst, S. Lundgren, H. Fjosne, O. Haraldseth (2000)
Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRIEuropean Radiology, 10
S. Grobmyer, V. Mortellaro, J. Marshall, Giselle Higgs, S. Hochwald, N. Mendenhall, E. Copeland, W. Cance (2008)
Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?Journal of the American College of Surgeons, 206 5
M. Tilanus-Linthorst, A. Obdeijn, M. Bontenbal, M. Oudkerk (1997)
MRI in patients with axillary metastases of occult breast carcinomaBreast Cancer Research and Treatment, 44
Parvesh Sharma, Scott Brown, N. Bengtsson, Qizhi Zhang, G. Walter, S. Grobmyer, S. Santra, Huabei Jiang, E. Scott, B. Moudgil (2008)
Gold-Speckled Multimodal Nanoparticles for Noninvasive BioimagingChemistry of Materials, 20
H. Mumtaz, M. Hall-Craggs, T. Davidson, K. Walmsley, W. Thurell, M. Kissin, I. Taylor (1997)
Staging of symptomatic primary breast cancer with MR imaging.AJR. American journal of roentgenology, 169 2
V. Mortellaro, J. Marshall, S. Harms, S. Hochwald, E. Copeland, S. Grobmyer (2008)
Breast MR for the Evaluation of Occult Nipple DischargeThe American Surgeon, 74
S. Ueda, H. Tsuda, Hideki Asakawa, J. Omata, K. Fukatsu, N. Kondo, T. Kondo, Y. Hama, Katsumi Tamura, Jiro Ishida, Y. Abe, H. Mochizuki (2008)
Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancerBMC Cancer, 8
M. Memarsadeghi, C. Riedl, A. Kaneider, A. Galid, M. Rudas, W. Matzek, T. Helbich (2006)
Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.Radiology, 241 2
Purpose To determine the utility of MRI for assessing axillary lymph node status in patients with breast cancer. Materials and Methods A consecutive series of patients who underwent breast MR before surgical management of breast cancer with axillary sampling between 2005 and 2007 were identified. MRs were evaluated for the number of nodes, contrast kinetics, nodal area, and number of nodes with no fatty hilum. Data were analyzed in the context of final breast pathology, sentinel lymph node status, and axillary nodal status. Correlations were analyzed using Kendall's τ‐b test. Reported P values are one‐sided. Results Fifty‐six females (median = 58 years) were studied. Sentinel lymph nodes (SLN) were positive in 15/56 patients (27%). All SLN + patients (n = 15) had completion axillary dissection. Extent of nodal disease was 1 (n = 3), 2 (n = 4), >2 (n = 8). Presence of any axillary lymph node with no fatty hilum and the number of nodes with no fatty hilum on MR significantly correlated with pathologic node positivity (P = 0.04); while kinetics, node number, and node size did not correlate. Conclusion Breast MR may be useful in the assessment of axillary nodes in patients with breast cancer. J. Magn. Reson. Imaging 2009. © 2009 Wiley‐Liss, Inc.
Journal of Magnetic Resonance Imaging – Wiley
Published: Aug 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.